Using photovoice methodology to uncover individual-level, health systems, and contextual barriers to uptake of second dose of measles containing vaccine in Western Area Urban, Sierra Leone, 2020.

Community participation Immunization barriers MCV2 Photovoice SHOWeD

Journal

Vaccine: X
ISSN: 2590-1362
Titre abrégé: Vaccine X
Pays: England
ID NLM: 101748769

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 04 11 2022
revised: 30 05 2023
accepted: 23 06 2023
medline: 14 8 2023
pubmed: 14 8 2023
entrez: 14 8 2023
Statut: epublish

Résumé

Vaccination coverage for the second dose of the measles-containing vaccine (MCV2) among children has remained stagnant in Sierra Leone at nearly 67% since its introduction in 2015. Identifying community-specific barriers faced by caregivers in accessing MCV2 services for their children and by health workers in delivering MCV2 is key to informing strategies to improve vaccination coverage. We used Photovoice, a participatory method using photographs and narratives to understand community barriers to MCV2 uptake from March- September 2020. Six female and five male caregivers of MCV2-eligible children (15-24 months of age), and six health care workers (HCWs) in Freetown, Sierra Leone participated. After having an orientation to photovoice, they photographed barriers related to general immunization and MCV2 uptake in their community. This was followed by facilitated discussions where participants elaborated on the barriers captured in the photos. Transcripts from the six immunization-related discussions were analyzed to deduce themes through open-ended coding. A photo exhibition was held for participants to discuss the barriers and suggested solutions with decision-makers, such as the ministry of health. We identified and categorized nine themes into three groups: 1) individual or caregiver level barriers (e.g., caregivers' lack of knowledge on MCV2, concerns about vaccine side effects, and gender-related barriers); 2) health system barriers, such as HCWs' focus on children below one year and usage of old child health cards; and 3) contextual barriers, such as poverty, poor infrastructure, and the COVID-19 pandemic. Participants suggested the decision-makers to enhance community engagement with caregivers and HCW capacity including, increasing accountability of their work using performance-based approaches, among different strategies to improve MCV2 uptake. Photovoice can provide nuanced understanding of community issues affecting MCV2. As a methodology, it should be integrated in broader intervention planning activities to facilitate the translation of community-suggested strategies into action.

Sections du résumé

Background UNASSIGNED
Vaccination coverage for the second dose of the measles-containing vaccine (MCV2) among children has remained stagnant in Sierra Leone at nearly 67% since its introduction in 2015. Identifying community-specific barriers faced by caregivers in accessing MCV2 services for their children and by health workers in delivering MCV2 is key to informing strategies to improve vaccination coverage.
Methods UNASSIGNED
We used Photovoice, a participatory method using photographs and narratives to understand community barriers to MCV2 uptake from March- September 2020. Six female and five male caregivers of MCV2-eligible children (15-24 months of age), and six health care workers (HCWs) in Freetown, Sierra Leone participated. After having an orientation to photovoice, they photographed barriers related to general immunization and MCV2 uptake in their community. This was followed by facilitated discussions where participants elaborated on the barriers captured in the photos. Transcripts from the six immunization-related discussions were analyzed to deduce themes through open-ended coding. A photo exhibition was held for participants to discuss the barriers and suggested solutions with decision-makers, such as the ministry of health.
Results UNASSIGNED
We identified and categorized nine themes into three groups: 1) individual or caregiver level barriers (e.g., caregivers' lack of knowledge on MCV2, concerns about vaccine side effects, and gender-related barriers); 2) health system barriers, such as HCWs' focus on children below one year and usage of old child health cards; and 3) contextual barriers, such as poverty, poor infrastructure, and the COVID-19 pandemic. Participants suggested the decision-makers to enhance community engagement with caregivers and HCW capacity including, increasing accountability of their work using performance-based approaches, among different strategies to improve MCV2 uptake.
Conclusion UNASSIGNED
Photovoice can provide nuanced understanding of community issues affecting MCV2. As a methodology, it should be integrated in broader intervention planning activities to facilitate the translation of community-suggested strategies into action.

Identifiants

pubmed: 37577263
doi: 10.1016/j.jvacx.2023.100338
pii: S2590-1362(23)00079-7
pmc: PMC10422676
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100338

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

© 2023 Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Vaccine. 2019 Jan 7;37(2):219-222
pubmed: 28760612
J Glob Health. 2020 Jun;10(1):010420
pubmed: 32509292
Health Educ Behav. 1997 Jun;24(3):369-87
pubmed: 9158980
BMJ Open. 2022 Mar 15;12(3):e057245
pubmed: 35292500
PLoS One. 2015 Aug 28;10(8):e0135222
pubmed: 26317975
BMC Med. 2021 Jan 5;19(1):2
pubmed: 33397366
Health Educ Q. 1988 Winter;15(4):351-77
pubmed: 3068205
Health Policy Plan. 2017 Dec 1;32(suppl_5):v13-v21
pubmed: 29244103
Health Res Policy Syst. 2021 Aug 11;19(Suppl 2):88
pubmed: 34380510
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Jan;63(1):25-31
pubmed: 31802153
Am J Health Promot. 1996 Mar-Apr;10(4):282-98
pubmed: 10159709
Vaccine. 2016 Nov 4;34(46):5495-5503
pubmed: 27692772
Qual Health Res. 2016 Jan;26(1):92-104
pubmed: 26679942
Health Educ Q. 1988 Winter;15(4):379-94
pubmed: 3230016
BMC Public Health. 2017 Jun 8;17(1):556
pubmed: 28595624
Int J Infect Dis. 2012 Feb;16(2):e136-45
pubmed: 22197748
Pan Afr Med J. 2020 Jan 03;35(Suppl 1):5
pubmed: 32373256
Vaccine. 2021 Apr 22;39(17):2434-2444
pubmed: 33781603
BMJ Glob Health. 2019 Sep 13;4(5):e001711
pubmed: 31565415
Pan Afr Med J. 2017 Jun 21;27(Suppl 3):4
pubmed: 29296139
J Immunol Sci. 2018 Jul 28;Suppl:113-121
pubmed: 30766972
PLoS One. 2019 Jun 20;14(6):e0213882
pubmed: 31220092
Glob Health Sci Pract. 2021 Sep 30;9(3):498-507
pubmed: 34593577
PLoS One. 2021 Oct 22;16(10):e0258252
pubmed: 34679104

Auteurs

Shibani Kulkarni (S)

U.S. Centers for Disease Control and Prevention, Atlanta GA, USA.

Atsuyoshi Ishizumi (A)

U.S. Centers for Disease Control and Prevention, Atlanta GA, USA.

Oliver Eleeza (O)

ICAP Sierra Leone, Freetown, Sierra Leone.

Palak Patel (P)

U.S. Centers for Disease Control and Prevention, Atlanta GA, USA.

Mohamed Feika (M)

ICAP Sierra Leone, Freetown, Sierra Leone.

Samilia Kamara (S)

ICAP Sierra Leone, Freetown, Sierra Leone.

Jerikatu Bangura (J)

ICAP Sierra Leone, Freetown, Sierra Leone.

Unisa Jalloh (U)

ICAP Sierra Leone, Freetown, Sierra Leone.

Musa Koroma (M)

ICAP Sierra Leone, Freetown, Sierra Leone.

Zainab Sankoh (Z)

ICAP Sierra Leone, Freetown, Sierra Leone.

Henry Sandy (H)

ICAP Sierra Leone, Freetown, Sierra Leone.

Mame Toure (M)

ICAP Sierra Leone, Freetown, Sierra Leone.

Thompson Uwhomena Igbu (TU)

World Health Organization, Freetown, Sierra Leone.

Tom Sesay (T)

Sierra Leone Ministry of Health and Sanitation, Freetown, Sierra Leone.

Ruby N Fayorsey (RN)

ICAP, NY, USA.

Neetu Abad (N)

U.S. Centers for Disease Control and Prevention, Atlanta GA, USA.

Classifications MeSH